Aclaris Therapeutics Inc (NASDAQ:ACRS)
| 9.15 BATS BZX Real-Time Price As of 3:40pm ET |  +0.36 / +4.10%Today’s Change | 5.77 Today|||52-Week Range 18.96 | -41.90% Year-to-Date |
Latest ACRS News | Press Releases
No recent news for Aclaris Therapeutics Inc.
Today’s Trading
| Previous close | 8.79 |
| Today’s open | 8.72 |
| Day’s range | 8.72 - 9.33 |
| Volume | 19,322 |
| Average volume (3 months) | 988,437 |
| Market cap | $621.3M |
Data as of 3:40pm ET, 06/05/2023
Growth & Valuation
| Earnings growth (last year) | +16.79% |
| Earnings growth (this year) | -34.22% |
| Earnings growth (next 5 years) | +38.60% |
| Revenue growth (last year) | +340.05% |
| P/E ratio | NM |
| Price/Sales | 34.52 |
| Price/Book | 2.97 |
Competitors
| ---- | ||
| --Microalliance Group ... | 0.00 | 0.00% |
| TBPHTheravance Biopharma... | +0.04 | +0.32% |
| SVASinovac Biotech Ltd | 0.00 | 0.00% |
Data as of 3:39pm ET, 06/05/2023
Financials
| Next reporting date | August 3, 2023 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $29.8M |
| Annual profit (last year) | -$86.9M |
| Net profit margin | -292.11% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Wayne, Pennsylvania |
Forecasts
